MORINAGA-MILK-INDUSTRY
9.7.2020 20:02:07 CEST | Business Wire | Press release
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company and a key global probiotics manufacturer, confirmed that its proprietary probiotic strain Bifidobacterium breve A1 (a.k.a. B. breve MCC1274) is safe and effective for improving memory functions of older adults with suspected mild cognitive impairment (MCI) in a randomized, double-blind, placebo-controlled trial (RCT).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200709005032/en/
The new study , published recently in the Journal of Alzheimer’s Disease, has produced breakthrough results uncovering a novel promising probiotic intervention for early dementia prevention. The clinical study conducted by a clinical research organization, Huma R&D Co., Ltd. in Tokyo, Japan, in collaboration with Morinaga Milk Industry Co., Ltd, is the first RCT report to show a profound cognitive enhancement benefit of the probiotic B. breve A1 in subjects with suspected MCI.
“Our findings represent an important breakthrough for MCI and dementia prevention,” says Dr. Xiao, Director of Next Generation Science Institute of Morinaga Milk, and a principal investigator of the trial. “It marks major progress in our investigation on the ability of the probiotic strain B. breve A1 to halt the cognitive decline of older adults.”
Globally, the number of people living with dementia, including Alzheimer’s disease, will increase from 50 million in 2018 to 152 million in 2050, reaching epidemic proportions. According to the Alzheimer’s Association website, it is estimated that one new patient is diagnosed with Alzheimer’s disease every 65 seconds (https://www.alz.org/alzheimers-dementia/facts-figures ), causing an unprecedented burden to society.
MCI is a common problem in older adults associated with the risk of developing sporadic Alzheimer’s disease or other dementia within a few years if left untreated. Currently, no medications have proven effective for MCI. Although several trials of pharmacological treatments were thought to prevent the symptoms of MCI, the results have been disappointing. Hence, there is an urgent need to identify effective countermeasures to MCI and dementia.
Previous studies by Morinaga Milk Industry Co., Ltd. have demonstrated the potential of B. breve A1 to treat Alzheimer’s disease in a pre-clinical model and found that this probiotic strain can improve specific cognitive functions in subjects with MCI in a human clinical trial. The current study conducted on 80 healthy older adults with suspected MCI further confirmed the efficacy of B. breve A1 on cognitive improvement.
Remarkable Improvement in RBANS Total Score
Participants randomly received either B. breve A1 or placebo by capsule for 16 weeks. At the end of the study, Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) total score showed a significant 11.3-point improvement in those taking A1 compared to placebo, in particular for domain scores of immediate memory, visuospatial/constructional, and delayed memory. In addition, significant improvement of cognitive function was confirmed by another test, the Japanese version of the MCI Screen.
Dr. Xiao said, “It was exciting to see a clear and significant improvement of memory functions such as the awareness of who, when, and where. The 11.3-point improvement of RBANS total score seen after only 16 weeks of daily consumption of the probiotic B. breve A1 in healthy older adults with MCI is remarkable.”
“Our findings could signal a profound shift as to how MCI can be treated using probiotics. Future discoveries for the precise mechanisms as to how daily consumption of B. breve A1 can improve memory will open new opportunities and alternatives for not only MCI treatment but perhaps also for other CNS diseases associated with inflammation and memory impairment.”
First Evidence of HRB Probiotics in Improving Cognitive Function of MCI and Supporting Healthy Cognitive Ageing
Pioneer in bifidobacteria research, Morinaga Milk has been focusing on the study of bifidobacteria species that are naturally present in human intestines – human-residential bifidobacteria (HRB) – for over 50 years and discovered various health benefits of its HRB strains. To continue exploring the potential of its HRB strains, in recent years, the company has focused on the gut-brain connection – a rapidly growing area of probiotics research – and conducted various research on cognitive improvement.
Embracing a significant milestone, Morinaga Milk is delighted to have uncovered the beneficial effects of its proprietary probiotic B. breve A1 on memory improvement. B. breve A1 originating from newborn infants’ intestines is the first human-residential bifidobacteria (HRB) strain that shows great promise to improve the memory of older adults with MCI and support healthy cognitive ageing.
“This breakthrough study is yet another indication of our continuous efforts to add value to our premium line of HRB probiotic strains,” said Ko Shiino, General Manager of Sales and Marketing Department, International Division of Morinaga Milk. “This promising finding will open up new business opportunities and is potentially game-changing. We are excited about the potential implications of B. breve A1 as a novel practical approach to promote healthy ageing.”
About Morinaga Milk
Morinaga Milk Industry Co., Ltd. is one of the leading dairy product companies in Japan with a century of history harnessing the nutritional properties of dairy products and its functional ingredients. Morinaga Milk excels in innovative technology and offers various dairy products and other beneficial functional ingredients to customers throughout the world. Since the 1960s, Morinaga Milk has been engaged in research on the safety, functional health benefits, and mechanisms of action of probiotic bifidobacteria to better understand their role in maintaining human health. For more information about Morinaga Bifidobacteria, please visit us at http://bb536.jp/english/index.html .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200709005032/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Holiday Data From Xsolla Shows Players Are Shopping, Gifting, and Choosing Brands Inside Video Games16.11.2026 18:00:00 CET | Press release
New Survey of More Than 4,000 Players Finds 78% Play More During the Holidays and 82.5% Would Watch a Rewarded Ad in Exchange for a Bonus Offer Xsolla (USA), Inc., a global commerce company, today announced a new data and insights report on how players shop, spend, and respond to brands during the holiday season. Titled “Why Video Games Belong in Your Holiday Commerce Strategy,” the report draws on direct answers from more than 4,000 players, gathered through opt-in rewarded surveys on Xsolla Offerwall. Players chose to take part and received a reward for sharing, which makes the data first-party and consent-based. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261111104582/en/ Graphic: Xsolla The research builds on the conversation Xsolla opened at Advertising Week New York 2026 about how brands can reach players in more ways through video games. Combined with Xsolla’s insights into in-game purchasing behavior across an aud
The Rock-It Company Opens New Regional Office in Nashville16.11.2026 17:00:00 CET | Press release
The expansion demonstrates The Rock-It Company’s dedication to the iconic live music market and opens a new centralized hub that connects live events and luxury goods in a fast-growing region. The Rock-It Company, a global leader in live events and luxury goods logistics, announced the opening of a new regional office in Nashville, Tennessee, reinforcing its presence in one of the world's most important live music and cultural markets. The Nashville office brings together the full Rock-It platform with dedicated offices for Rock-It Cargo, Rock-It Sports, CARS by Rock-It and DIETL by Rock-It, serving as a regional hub for the company's broader portfolio of specialty logistics offerings. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261116286387/en/ The Rock-It Company office in Nashville, Tennessee “Nashville has been a central part of our business for decades, and we see tremendous opportunity to continue building on that f
IQM Supports NVIDIA’s Work to Make Quantum Computers Schedulable in Slurm16.11.2026 17:00:00 CET | Press release
IQM quantum computers already run at leading supercomputing centers, including Oak Ridge National Laboratory (ORNL), VTT Technical Research Centre of Finland, the Leibniz Supercomputing Centre (LRZ) and CINECA, with users reaching them through Slurm. IQM supports NVIDIA’s investment in making quantum processors a schedulable resource in supercomputing centers by integrating IQM quantum computers with Slurm. IQM’s partner MQSC (Munich Quantum Software Company) has demonstrated the MQSC Orchestrator scheduling IQM systems through the new Slurm capability. IQM Quantum Computers (Nasdaq: IQMX), a global leader in superconducting quantum computers, today announced at SC26 in Chicago its support for NVIDIA’s investment in making quantum processing units (QPUs) a schedulable resource in the Slurm workload manager by integrating IQM quantum computers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261116814640/en/ NVIDIA is making q
What Our Pupils Reveal: MindMetrix Joins Wyss Geneva to Bring Eye-Based Biofeedback to Mental Health16.11.2026 15:45:00 CET | Press release
We are proud to welcome MindMetrix AG as one of the newest Wyss Geneva ventures. Born out of research at ETH Zurich’s Neural Control of Movement Lab, MindMetrix is a neurotechnology company that reads the brain’s arousal system through the eyes and turns it into live biofeedback, so people can see, and learn to regulate, their own mental state. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261116303495/en/ MindMetrix’s myflow platform turns pupil-based measurements into live biofeedback, with each user’s training sessions and progress shown in a dashboard. Image: MindMetrix The mind is still assessed mostly through questionnaires and self-report, with no objective, real-time measure of brain activity. The size of our pupils changes with the brain’s arousal center, a tiny region deep in the brainstem that is otherwise hard to observe without a brain scan. MindMetrix uses pupillometry to read that signal and turn it into live
Factbird Launches Visual Intelligence and Factbird MCP: AI That Sees the Shop Floor and Connects to Any AI Assistant16.11.2026 15:39:00 CET | Press release
Two new AI capabilities, available now. Visual Intelligence turns camera footage into production data. Factbird MCP gives AI assistants direct access to production data in Factbird. Today, Factbird announces the launch of two new AI capabilities. Visual Intelligence uses cameras and AI to measure what sensors and PLCs miss. Factbird MCP lets AI assistants such as Claude, ChatGPT, and Microsoft Copilot work directly with production data in Factbird. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261113769016/en/ Factbird Visual Intelligence tracking a bottling line in real time, showing filler and shrink wrapper status, line speed of 72 bottles per minute, and operator activity around the line. (AI-generated illustration) The losses that are hardest to explain happen around the machine. A station waits for material. A manual task runs long on the night shift. Each one costs a few minutes, and over a year they add up to real c
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
